Abstract:Background Integrative analysis approaches of metagenomics and metabolomics have been widely developed to understand the association between disease and the gut microbiome. However, the different profiling patterns of different metabolic samples in the association analysis make it a matter of concern which type of sample is the most closely associated with gut microbes and disease. To address this lack of knowledge, we investigated the association between the gut microbiome and metabolomic profiles of stool, urine, and plasma samples from ischemic stroke patients and healthy subjects. Methods We performed metagenomic sequencing (feces) and untargeted metabolomics analysis (feces, plasma, and urine) from ischemic stroke patients and healthy volunteers. Differential analyses were conducted to find key differential microbiota and metabolites for ischemic stroke. Meanwhile, Spearman's rank correlation and linear regression analyses were used to study the association between microbiota and metabolites of different metabolic mixtures. Results Untargeted metabolomics analysis shows that feces had the most abundant features and identified metabolites, followed by urine and plasma. Feces had the highest number of differential metabolites between ischemic stroke patients and the healthy group. Based on the association analysis between metagenomics and metabolomics of fecal, urine, and plasma, fecal metabolome showed the strongest association with the gut microbiome. There are 1073, 191, and 81 statistically significant pairs (P < 0.05) in the correlation analysis for fecal, urine, and plasma metabolome. Fecal metabolites explained the variance of alpha-diversity of the gut microbiome up to 31.1%, while urine and plasma metabolites only explained the variance of alpha-diversity up to 13.5% and 10.6%. Meanwhile, there were more significant differential metabolites in feces than urine and plasma associated with the stroke marker bacteria. Conclusions The systematic association analysis between gut microbiome and metabolomics reveals that fecal metabolites show the strongest association with the gut microbiome, followed by urine and plasma. The findings would promote the association study between the gut microbiome and fecal metabolome to explore key factors that are associated with diseases. We also provide a user-friendly web server and a R package to facilitate researchers to conduct the association analysis of gut microbiome and metabolomics.

The roles and mechanisms of gut microbiome and metabolome in patients with cerebral infarction

Analysis of intestinal microbial communities of cerebral infarction and ischemia patients based on high throughput sequencing technology and glucose and lipid metabolism

Role of the gut microbiota in complications after ischemic stroke

Gut Microbiota in Ischemic Stroke: Role of Gut Bacteria-Derived Metabolites

Multi-omics reveals specific host metabolism-microbiome associations in intracerebral hemorrhage

The role of gut microorganisms and metabolites in intracerebral hemorrhagic stroke: a comprehensive review

Relationship Between the Gut Microbiota and Neurological Deficits in Patients With Cerebral Ischemic Stroke

Role of Gut Microbiota in Ischemic Stroke: A Narrative Review of Human and Animal Studies

The gastrointestinal-brain-microbiota axis: a promising therapeutic target for ischemic stroke

Pivotal Interplays Between Fecal Metabolome and Gut Microbiome Reveal Functional Signatures in Cerebral Ischemic Stroke

How Brain Infarction Links With the Microbiota–Gut–Brain Axis: Hints From Studies Focusing on the Risk Factors for Ischemic Stroke

Gut microbes in cerebrovascular diseases: Gut flora imbalance, potential impact mechanisms and promising treatment strategies

The Role of the Gut Microbiome and Its Metabolites in Cerebrovascular Diseases

16S rRNA gene sequencing and LC-MS-based metabolomics show that ischemic stroke is related to gut microbiota and metabolome in rats

Integrated 16S rRNA Gene Sequencing and LC-MS Analysis Revealed the Interplay Between Gut Microbiota and Plasma Metabolites in Rats With Ischemic Stroke

Therapeutic approaches targeting the gut microbiota in ischemic stroke: current advances and future directions

Microbiome Signatures in Ischemic Stroke: A Systematic Review

The interaction between intestinal microenvironment and stroke

Identification of Potential Diagnostic Biomarkers of Cerebral Infarction Using Gas Chromatography-Mass Spectrometry and Chemometrics

Metabolomic discoveries for early diagnosis and traditional Chinese medicine efficacy in ischemic stroke

Crosstalk between the Gut and Brain in Ischemic Stroke: Mechanistic Insights and Therapeutic Options